Altamira Therapeutics CYTOF Income Statement (2016-2025)

OTC CYTOF
$0.09 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Altamira Therapeutics Quarterly Income Statement

Periods 17 quarters
Latest Jun 2025

Altamira Therapeutics income statement data for the quarter ended Jun 2025. This income statement covers 17 quarters of results from Dec 2016 through Jun 2025, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2016 Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jan2023 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025
Additional items
Shares Outstanding 0.00M0.00M0.00M0.00M0.01M0.01M0.02M0.02M0.03M0.03M0.05M0.05M0.05M0.49M0.49M2.83M2.83M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.00M0.00M0.05M0.04M0.05M0.05M0.05M0.45M0.45M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.01M0.03M0.04M0.06M0.49M4.66M

Altamira Therapeutics Income Statement API

Pull Altamira Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CYTOF&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY